Back to CELG-RI
Candriam S.C.A. CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
6
Latest value
$76.6M
Q3 2026
Peak value
$76.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $40.5M |
| Q4 2025 | $48.9M |
| Q4 2025 | $48.9M |
| Q1 2026 | $49.8M |
| Q2 2026 | $68.9M |
| Q3 2026 | $76.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $76.6M | 1.22M | — | — |
| Q2 2026 | $68.9M | 1.20M | — | — |
| Q1 2026 | $49.8M | 821.6K | — | — |
| Q4 2025 | $48.9M | 906.7K | — | — |
| Q4 2025 | $48.9M | 906.7K | — | — |
| Q3 2025 | $40.5M | 897.3K | — | — |
Other funds holding CELG-RI
$11.1B
$9.6B
$8.5B
$7.9B
$5.9B
$5.9B
$5.8B